- Home
- Equipment
- north america
- percutaneous coronary intervention
Show results for
Refine by
Percutaneous Coronary Intervention Equipment Supplied In North America
9 equipment items found
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Extraordinary Deliverability. Ultra Low Profile. Target Eluting Technology of ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
CoCr Stent Platform. Reliable durable polymer-Styrene Butylenes Styrene. Uniform sine wave design provides uniform support strength and ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
TARGET All Comers Trial: 1,656 Patients from 20 sites in Europe. 1:1 RCT Real World open-label, non-inferiority trial Primary endpoint: TLF @12 months. Confirms that the Firehawk®, a low dose sirolimus eluting biodegradable polymer DES, is safe. and effective across a broad spectrum of patient and lesion complexity. ...
Manufactured by:OrbusNeich Medical Company Ltd. based inShatin, N.T., CHINA
The Smart Solution for complex PCI Patients. Diamondback 360 Coronary Orbital Atherectomy System (OAS) reduces severe calcium, enabling successful stent delivery to help optimize stent expansion and percutaneous coronary intervention (PCI) ...
Manufactured by:OpSens Medical, a division of OpSens based in, QUEBEC (CANADA)
OpSens OptoWire is a modern pressure guidewire designed to assess stenoses in vessels such as coronary arteries. OptoWire is powered by Fidela™, a patented 2nd generation fiber optic sensor to measure physiologic indices including Fractional Flow Reserve (FFR and diastolic Pressure Ratio (dPR). ...
by:Supira Medical based inLos Gatos, CALIFORNIA (USA)
Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Delcasertib (KAI-9803) is a potent and selective δ-protein kinase C (δPKC) inhibitor. Delcasertib (KAI-9803) could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
Manufactured by:Second Heart Assist, Inc. based inSalt Lake City, UTAH (USA)
Second Heart Assist objectives are to improve the quality of life by reducing the heart’s work-load and improve perfusion. The enhancement of renal function reduces risks associated with toxic contrasts used in percutaneous catheterization interventions (High Risk PCI). Additionally, the product helps patients recover from cardiogenic shock and get acute decompensating heart failure ...